# SIMBRINZA
> **NDA204251** · New Drug Application · Sponsor: ALCON LABS INC · Approved 2013-04-19
## Drug
- **FDA Application Number:** NDA204251
- **Application type:** New Drug Application
- **Brand name:** SIMBRINZA
- **Generic name:** BRINZOLAMIDE/BRIMONIDINE TARTRATE
- **Active ingredients:** BRIMONIDINE TARTRATE; BRINZOLAMIDE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** ALCON LABS INC
- **Manufacturer:** Alcon Laboratories, Inc.
- **First approval:** 2013-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204251)
---
*MORVS · CC0 1.0*